| Systematic (IUPAC) name | |
|---|---|
| (2-(5-methyl-1H-indol-3-yl)-1-methyl-ethyl)dimethylamine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 22120-39-4 |
| ATC code | ? |
| PubChem | CID 1837 |
| ChemSpider | 1771 |
| Chemical data | |
| Formula | C13H18N2 |
| Mol. mass | 202.30 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
5,N,N-trimethyltryptamine (5,N,N-TMT; 5-TMT) is a tryptamine derivative that is a hallucinogenic drug. It was first made in 1958 by E. H. Young. [1] In animal experiments it was found to be in between DMT and 5-MeO-DMT in potency [2][3] which would suggest an active dosage for humans in the 20–60 mg range. Human psychoactivity for this compound has been claimed in reports on websites such as Erowid but has not been independently confirmed.
| This psychedelics, dissociatives and deliriants-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)